Catalog No.
YVV31401
Expression system
E. coli
Species
Zika virus (isolate ZIKV/Human/French Polynesia/10087PF/2013) (ZIKV)
Protein length
Ile291-Ser751
Predicted molecular weight
52.14 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
A0A024B7W1
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Genome polyprotein, Envelope protein E
Ubiquitin-like modifier-activating enzyme 1 interacts with Zika virus NS5 and promotes viral replication in the infected cell., PMID:39773572
Honokiol and Alpha-Mangostin Inhibit Mayaro Virus Replication through Different Mechanisms., PMID:36364188
Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural progenitor cells., PMID:36174572
ZIKV-envelope proteins induce specific humoral and cellular immunity in distinct mice strains., PMID:36131132
Targeting Host PIM Protein Kinases Reduces Mayaro Virus Replication., PMID:35216015
Structurally Conserved Domains between Flavivirus and Alphavirus Fusion Glycoproteins Contribute to Replication and Infectious-Virion Production., PMID:34757841
Performance assessment of a multi-epitope chimeric antigen for the serological diagnosis of acute Mayaro fever., PMID:34321560
Acidic pH-Induced Conformational Changes in Chikungunya Virus Fusion Protein E1: a Spring-Twisted Region in the Domain I-III Linker Acts as a Hinge Point for Swiveling Motion of Domains., PMID:32938768
Ginkgolic acid inhibits fusion of enveloped viruses., PMID:32179788
Prediction of Epitope-Based Peptide Vaccine Against the Chikungunya Virus by Immuno-informatics Approach., PMID:31721709
A rapid strategy for constructing novel simian adenovirus vectors with high viral titer and expressing highly antigenic proteins applicable for vaccine development., PMID:31108113
Viral Exploration of Negative Acute Febrile Cases Observed during Chikungunya Outbreaks in Gabon., PMID:30625488
Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development., PMID:30557365
Neuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1 Glycoprotein., PMID:30111563
A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections., PMID:29807712
Human Antibody Responses to Emerging Mayaro Virus and Cocirculating Alphavirus Infections Examined by Using Structural Proteins from Nine New and Old World Lineages., PMID:29577083
Autochthonous Transmission of East/Central/South African Genotype Chikungunya Virus, Brazil., PMID:28930027
Structural Mimicry of the Dengue Virus Envelope Glycoprotein Revealed by the Crystallographic Study of an Idiotype-Anti-idiotype Fab Complex., PMID:28637753
[Not Available]., PMID:28527274
Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential., PMID:28461071
Obatoclax Inhibits Alphavirus Membrane Fusion by Neutralizing the Acidic Environment of Endocytic Compartments., PMID:27993855
Dengue Virus Genome Uncoating Requires Ubiquitination., PMID:27353759
Production of Chikungunya Virus-Like Particles and Subunit Vaccines in Insect Cells., PMID:27233282
For research use only. Not for human or drug use.
